Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin slows down hair growth in mice.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

A patient produced cortisol after adrenalectomy, possibly due to residual tissue or other body parts making steroids.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Topical corticosteroids can cause serious side effects like Cushing's syndrome and hirsutism.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Stopping steroids and providing supportive care improved the patient's Cushing Syndrome symptoms and ulcers.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.